Advertisement
Screener

Indaptus Therapeutics, Inc. (INDP) Material Contracts

Indaptus Therapeutics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-09-10: Form 8-K; Exhibit 10.1; Description Form of Stock Purchase Agreement, dated September 8, 2026.
  • 2026-06-24: Form 8-K; Exhibit 10.1; Description Form of Stock Purchase Agreement, dated June 17, 2026.
  • 2026-04-23: Form 8-K; Exhibit 10.2; Description Form of Indemnification Agreement.
  • 2026-04-23: Form 8-K; Exhibit 10.1; Description Form of Independent Director Agreement.
FiledFormExhibitDescription
2026-09-108-K10.1Form of Stock Purchase Agreement, dated September 8, 2026
2026-06-248-K10.1Form of Stock Purchase Agreement, dated June 17, 2026
2026-04-238-K10.2Form of Indemnification Agreement
2026-04-238-K10.1Form of Independent Director Agreement
2026-02-128-K10.2Form of Voting Agreement
2026-02-128-K10.1Form of Warrant Repricing Agreement
2026-01-208-K10.2Salary Adjustment Agreement dated January 20 between the Company and Michael J. Newman, Ph.D.
2026-01-208-K10.1Salary Adjustment Agreement dated January 20 between the Company and Jeffrey A. Meckler
2025-12-238-K10.7Form of Voting Agreement
2025-12-238-K10.6Separation Agreement, dated as of December 22, 2025, by and between the Company and Roger Waltzman
2025-12-238-K10.5Employment Modification Agreement, dated as of December 22, 2025, by and between the Company and Walt A. Linscott, Esq.
2025-12-238-K10.4Employment Modification Agreement, dated as of December 22, 2025, by and between the Company and Nir Sassi
2025-12-238-K10.3Employment Modification Agreement, dated as of December 22, 2025, by and between the Company and Michael J. Newman, Ph.D.
2025-12-238-K10.2Employment Modification Agreement, dated as of December 22, 2025, by and between the Company and Jeffrey A. Meckler
2025-12-238-K10.1Securities Purchase Agreement, dated as of December 22, 2025, by and between the Company and David Lazar
2025-06-138-K10.4Form of Placement Agent Agreement, dated as of May 9, 2025, by and between Indaptus Therapeutics, Inc. and Paulson Investment Company, LLC
2025-06-138-K10.3Form of Common Warrant
2025-06-138-K10.2Form of Convertible Promissory Note
2025-06-138-K10.1Form of Securities Purchase Agreement, dated as of June 12, 2025, between the Company and the investors signatory thereto
2025-02-128-K10.1Form of Standby Equity Purchase Agreement dated as of February 12, 2025 by and between the Company and YA II PN Ltd.
2025-01-148-K10.4Placement Agent Agreement, dated as of December 12, 2024, by and between Indaptus Therapeutics, Inc. and Paulson Investment Company, LLC as amended by the First Amendment to the Placement Agent Agreement, dated as of December 30, 2024
2025-01-148-K10.3Form of Placement Agent Warrant
2025-01-148-K10.2Form of Warrant
2025-01-148-K10.1Form of Securities Purchase Agreement
2024-11-228-K10.3Form of Placement Agent Warrant
2024-11-228-K10.2Form of Warrant
2024-11-228-K10.1Form of Securities Purchase Agreement
2024-08-088-K10.2Form of Warrant
2024-08-088-K10.1Form of Securities Purchase Agreement
2024-06-078-K10.1Indaptus Therapeutics, Inc. Amended and Restated 2021 Stock Incentive Plan
2024-03-1310-K10.8Employment Agreement between Roger J. Waltzman and Indaptus Therapeutics, Inc., effective as of August 7, 2023
2023-05-1110-Q10.1Indaptus Therapeutics, Inc. Non-Employee Director Compensation Program (Effective April 2, 2023)
2023-03-1710-K10.2Form of Option Award Agreement
2023-03-1710-K10.1Indaptus Therapeutics, Inc. 2021 Stock Incentive Plan
2022-12-238-K10.2Registration Rights Agreement, dated December 22, 2022, by and between Indaptus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC
2022-12-238-K10.1Purchase Agreement, dated December 22, 2022, by and between Indaptus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC
2022-03-2110-K10.7Employment Agreement with Boyan Litchev and Indaptus Therapeutics, Inc., effective as of January 31, 2022
2022-03-2110-K10.6Employment Agreement between Nir Sassi and Indaptus Therapeutics, Inc., effective as of January 1, 2022
2021-08-068-K10.7First Amendment to the Indaptus Therapeutics, Inc. 2021 Stock Incentive Plan
2021-08-068-K10.5Form of Indemnification Agreement
2021-08-068-K10.4Services Agreement between Nir Sassi and Indaptus Therapeutics, Inc., dated August 5, 2021
2021-08-068-K10.3Employment Agreement between Walt Linscott and Indaptus Therapeutics, Inc., effective as of August 4, 2021
2021-08-068-K10.2Employment Agreement between Michael J. Newman, Ph.D. and Indaptus Therapeutics, Inc., effective as of August 4, 2021
2021-08-068-K10.1Employment Agreement between Jeffrey Meckler and Indaptus Therapeutics, Inc., effective as of August 4, 2021
2021-07-298-K10.5Engagement Letter
2021-07-298-K10.4Form of Registration Rights Agreement
2021-07-298-K10.3Form of Warrant
2021-07-298-K10.2Form of Pre-funded Warrant
2021-07-298-K10.1Form of Securities Purchase Agreement
2021-06-2810-Q10.1First Amendment to Ordinary Shares Purchase Agreement, dated as of May 16, 2021, between Intec Pharma Ltd. And Aspire Capital Fund LLC

Similar stocks

Stock NameCountryMarket CapPE Ratio
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82